SUMMARY
Peroxiredoxins (Prxs) are ubiquitous cysteine-based peroxidases that guard cells against oxidative damage, are virulence factors for pathogens, and are involved in eukaryotic redox regulatory pathways. We have analyzed catalytically active crystals to capture atomic resolution snapshots of a PrxQ-subfamily enzyme (from Xanthomonas campestris) proceeding through thiolate, sulfenate, and sulfinate species. These analyses provide structures of unprecedented accuracy for seeding theoretical studies, and show novel conformational intermediates giving insight into the reaction pathway. Based on a highly non-standard geometry seen for the sulfenate intermediate, we infer that the sulfenate formation itself can strongly promote local unfolding of the active site to enhance productive catalysis. Further, these structures reveal that preventing local unfolding, in this case via crystal contacts, results in facile hyperoxidative inactivation even for Prxs normally resistant to such inactivation. This supports previous proposals that conformation-specific inhibitors may be useful for achieving selective inhibition of Prxs that are drug targets.
Graphical Abstract

INTRODUCTION
Peroxiredoxins (Prxs) are ubiquitous peroxidases and in humans and other mammals they modulate peroxide signaling events that regulate biological phenomena such as cortisol production, cell senescence, and apoptosis (Hall et al., 2009)(Wood et al., 2003)(Perkins et al., 2014)(Rhee et al., 2012)(Kil et al., 2012). Prxs utilize a highly efficient cysteine-based mechanism to reduce hydrogen peroxide, organic hydroperoxides, and peroxynitrite at rates contants on the order of 103–107 M−1 s−1 (Perkins et al., 2015). Though they perform catalysis in diverse ecological niches and redox environments, Prxs share a PxxxT/SxxC motif and conserved Arg (Nelson et al., 2010) that form a consistently organized active site (Fig. 1A, Fig. S1). The active site cysteine, referred to as the peroxidatic Cys (CP), is stabilized as a reactive Cys-thiolate (CP-S−) by the active site environment and attacks a bound hydrogen peroxide to form Cys-sulfenate (CP-SO−) and water (Perkins et al., 2015)(Zeida et al., 2014)(Nagy et al., 2011)(Portillo-Ledesma et al., 2014). Most Prxs then undergo a substantial structural rearrangement to a locally unfolded (LU) conformation to allow CP to form a disulfide with a second, often distant, resolving Cys (CR). Subsequently, the CP-CR disulfide is reduced, commonly by thioredoxin, to regenerate the reactive CP-S− in the fully folded (FF) conformation (Perkins et al., 2015).
Figure 1.

Summary of proposed mechanisms of Prx peroxidation. A. Overlay of active sites of DTT-bound human PrxV (light blue) and peroxide-bound ApTpx (green) with water-bound wild-type XcPrxQ (white), with ligands colored cyan (DTT), lime (H2O2), and dark gray (waters), respectively. Dashed lines indicate active site interactions for XcPrxQ, including a contact between the CδH of Tyr40 with the thiolate that would also contribute weak electrostatic stabilization to the thiolate. This appears to be a conserved interaction in FF Prx structures and involves either a Tyr or His. B–D. Previous studies do not provide a consensus on how Prx catalysis proceeds, as evident by the many different hydrogen bond interactions and residue shifts proposed. Hydrogen bonds seen in the XcPrxQ structures in this study (dark gray arrows pointing from donor to acceptor) for the substrate-bound state, the inferred transition state (based on relative rigidity of active site residues), and the product states, are compared with those proposed by previous studies: brown arrows for Hall et al. (Hall et al., 2010), blue arrows for Portillo et al. (Portillo-Ledesma et al., 2014), green arrows for Zeida et al. (Zeida et al., 2014), and pink arrows for Nagy et al. (Nagy et al., 2011). Shifts in residue positions are noted by thick arrows (Thr shift in blue panels C/D and Pro shift in dark gray in panel D). Forming and breaking covalent bonds are depicted as double dashed lines. Atoms not incorporated into previous QM simulations, presumably because they were not thought to play key roles in the chemistry of catalysis, are highlighted in yellow in panel B. The circled hydrogen and dashed arrow in panel D notes a predicted proton transfer by Portillo et al. (Portillo-Ledesma et al., 2014). See also Fig. S1 for an analysis of available Prx crystal structures.
An additional complexity of Prx catalysis is a regulatory feature associated with further oxidation of CP: if the FF active site is sufficiently stabilized and unfolding inhibited, a second peroxide can inactivate the enzyme by reacting with the FF CP-SO− to “hyperoxidize” it to a Cys-sulfinate (CP-SO2−) (Wood et al., 2003). So-called ‘sensitive’ Prxs of mammals and other eukaryotes that are readily hyperoxidized are thought to use this shunt for purposeful substrate-induced inactivation that enhances redox signaling possibly through allowing peroxide to persist and oxidatively regulate downstream targets (Wood et al., 2003). Such organisms also possess the enzyme sulfiredoxin (Srx) to resurrect hyperoxidized Prxs (Perkins et al., 2014). In contrast, ‘robust’ Prxs such as those from bacterial pathogens are thought to only be used for oxidative defense and have been evolutionarily optimized to resist hyperoxidation, even at millimolar concentrations of peroxides (Wood et al., 2003)(Lowther and Haynes, 2010).
Although previous studies have provided an excellent framework for understanding the Prx reaction pathway, important ambiguities remain regarding catalysis and hyperoxidation. Analysis of substrate-bound experimental structures (Hall et al., 2010) and computational studies (Zeida et al., 2014)(Nagy et al., 2011)(Portillo-Ledesma et al., 2014) have not yielded clarity about how the initial peroxidase step achieves a ~102–106 M−1 s−1 enhancement over free thiol (Nagy et al., 2011), with recent studies proposing differences in the key interactions occurring between CP, the substrate, and the conserved Arg and Thr side chains (Fig. 1B–D)(Hall et al., 2010)(Zeida et al., 2014)(Portillo-Ledesma et al., 2014). Also poorly understood is the extent to which CP-SO− formation may promote local unfolding. Structural data for this state is limited to a few structures that do not show consistent interactions (Fig. S1), and due to the reactive nature of sulfenate/sulfenic acid, there can be uncertainty regarding the true redox state being observed (Perkins et al., 2013). The most thorough analysis to date comes from a study of four crystal structures (1.7 – 2.6 Å resolution) of the CP-SO− →CP-SO2− transition in Aeropyrum pernix thiol peroxidase (ApTpx) that reported an unexpected CP-sulfurane-His intermediate; but most Prxs do not contain this His residue, so such an intermediate cannot be present for the majority of Prxs (Nakamura et al., 2008).
To work towards resolving discrepancies in proposed peroxidation mechanisms and elucidate the relevant structural details important for unfolding and hyperoxidation, we sought a model system that could provide high resolution snapshots of Prx catalysis at all stages (e.g. CP-S− ; CP-SO− ; CP-SO2− ; the CP-CR disulfide ; and FF and LU conformations). We chose for this purpose Xanthomonas campestris peroxiredoxin Q (XcPrxQ). The PrxQ subgroup (formerly called BCP) is found in diverse organisms including bacteria, archaea, plants, and fungi, but not animals (Perkins et al., 2015)(Nelson et al., 2010), and some members of this subgroup have been shown to be important for pathogen defenses (Perkins et al., 2014). XcPrxQ was attractive for several reasons: (1) it possesses active site features common to the majority of Prxs; (2) as a monomeric Prx, it is more amenable to NMR and computational analyses; (3) it has yielded high resolution structures of an FF form (a CP/CR→Ser double mutant at 1.5 Å, PDB entry 3gkm), and an LU disulfide form (1.8 Å, PDB entry 3gkk) (Liao et al., 2009); and (4) the FF crystal form had an accessible active site, potentially enabling in-crystal studies of ligand binding and catalysis. XcPrxQ has its CR residue in helix α3, and undergoes a FF→LU conformation change involving the flipping of the CP side chain and an unraveling of α3 (Liao et al., 2009) (see Figure 3A).
Figure 3.

Fully Folded and Locally Unfolded Conformations of XcPrxQ. A. The active FF conformation (left) and the LU disulfide conformation are shown (right) as cartoons colored by local mobility as indicated by B-factor, and with sticks for CP, CR and the conserved active site Pro, Thr and Arg. The largest conformation changes involve the helix 3 region that is highlighted in yellow. This structural rearrangement moves CP away from the active site pocket, disrupting all of its hydrogen bonding interactions, as described by Liao et al. (Liao et al., 2009). B. The active site of the XcPrxQ FF structure with 2FO-FC density (thin blue mesh 1.5 ρrms pink mesh 3.5 ρrms). C. Same as B but for the LU CP-CR disulfide structure.
Using this system, we have recently published the NMR backbone assignments for the reduced and oxidized states (Buchko et al., 2015) and here we report crystallographic studies that include analysis of wild-type crystals that are catalytically active and diffract better than anticipated. We have been able to capture at atomic resolution a full series of novel wild-type XcPrxQ structures that encompass the complete CP-S− → CP-SO− → CP-SO2− transition and provide novel insights into Prx catalysis. The in-crystal behavior also demonstrates the extent to which even a robust bacterial Prx can be made highly sensitive to hyperoxidative inactivation.
RESULTS AND DISCUSSION
Recombinant wild type XcPrxQ as well as its CP → Ser (C48S) and CR → Ser (C84S) mutants were prepared in good yields and behaved well in analyses (see Experimental Procedures). In addition to basic functional characterization of the wild type enzyme we report 15 crystal structures refined at resolutions of 1.0 – 1.35 Å (Table 1, Table S1) that include a series of 12 novel structures of the catalytically active crystals of the FF wild type enzyme at various stages along the catalytic cycle, and one novel structure each of the C48S and C84S mutants, and the wild type enzyme disulfide form solved at ~0.5 Å higher than in a previous study (Liao et al., 2009).
Table 1.
Data Collection and Refinement Statistics for Representative XcPrxQ Structures
| Data Collection | PDB code: 5iiz | PDB code: 5imc | PDB code: 5imf | PDB code: 5iny | PDB code: 5io2 |
|---|---|---|---|---|---|
| Structure | FF0 | FF3 | FF5 | FF8 | C48S |
| Space group | P21 | P21 | P21 | P21 | P21 |
| Unit cell a, b, c (Å), γ (°) | 35.4, 52.4, 40.0, 103.3 | 35.5, 51.2, 40.0,104.0 | 35.6, 51.5, 40.0, 104.1 | 35.6, 51.3, 40.0, 104.0 | 35.6, 51.3, 39.7, 103.8 |
| Resolution (Å) | 25.5–1.05 (1.11-)a | 10.6–1.05 (1.11-) | 23.2–1.04 (1.10-) | 11.5–1.04 (1.10-) | 30.8–1.20 (1.26-) |
| Completeness (%) | 98.0 (96.7) | 87.6 (50.0) | 90.5 (51.0) | 91.0 (51.3) | 86.4 (47.6) |
| Unique reflections | 63472 (9105) | 56804 (4673) | 60776 (4940) | 60675 (4932) | 37466 (2964) |
| Multiplicity | 7.0 (6.9) | 6.6 (4.5) | 6.3 (3.8) | 6.4 (3.8) | 3.6 (3.0) |
| Rmeas (%) | 11 (147) | 8 (95) | 10 (135) | 8 (125) | 10 (75) |
| CC1/2 | 1.0 (0.70) | 1.0 (0.72) | 1.0 (0.45) | 1.0 (0.51) | 1.0 (0.71) |
| <I/σ> | 11.8 (2.3) | 15.8 (2.0) | 11.3 (0.9) | 14.3 (1.3) | 8.4 (1.6) |
| <I/σ> ~2.0 (Å)b | - | 1.05 | 1.07 | 1.06 | 1.25 |
| Refinement | |||||
| Resolution range (Å) | 25.5–1.05 | 10.6–1.05 | 23.2–1.04 | 29.6–1.04 | 30.8–1.20 |
| R-factor (%) | 13.5 | 12.5 | 13.8 | 12.3 | 13.7 |
| R-free (%) | 15.3 | 14.4 | 16.0 | 14.5 | 16.7 |
| Protein residues | 159 | 158 | 159 | 159 | 159 |
| Water molecules | 261 | 308 | 316 | 311 | 325 |
| RMSD lengths (Å) | 0.007 | 0.015 | 0.013 | 0.011 | 0.012 |
| RMSD angles (°) | 1.0 | 2.0 | 1.8 | 1.7 | 1.3 |
| Ramachandran plotc | |||||
| φ, ψ-Preferred (%) | 100.0 | 100 | 100.0 | 99.4 | 100 |
| φ, ψ-Allowed (%) | 0.0 | 0.0 | 0.0 | 0.6 | 0.0 |
| φ, ψ-Outliers (%) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| B factorsd | |||||
| <Main chain> (Å2) | 11 | 8 | 8 | 9 | 9 |
| <Waters> (Å2) | 33 | 23 | 24 | 25 | 25 |
| Rxn progression (%) | pH=7.0 | pH=4.5 | pH=4.5 | pH=4.5 | pH=5.5 |
| S− | 100 | 50 | 55 | ||
| SO− | 50 | 15 | |||
| SO−inv | 10 | ||||
| SO2− | 20 | 100 | |||
Values in parenthesis are for the highest resolution shell and preceding values are for all data;
For reference to traditional resolution cutoffs, the point where <I/σ> falls to ~2.0 is provided;
Preferred, allowed, and outlier angles as assigned by Molprobity(Davis et al., 2004);
Outliers were generally in areas of weak density, such as the C-terminal region. Please also see Table S1 for crystallographic statistics for additional structures.
Basic functional characterization of XcPrxQ
In a standard Prx assay system, recombinant XcPrxQ reduced hydrogen peroxide and organic peroxides with kcat/Km values of ~3 × 104 M−1 s−1 (Fig. 2A–B, Table S2). This level of activity is typical for PrxQ representatives, which range from 0.8 × 104 to 4 × 104 M−1 s−1 (Reeves et al., 2011)(Rouhier et al., 2004)(Horta et al., 2010). The recombinant XcPrxQ was also relatively resistant to hyperoxidation in solution as is typical for bacterial Prxs (Fig. 2C–F) (Nelson et al., 2013). Quantifying the sensitivity using the Chyp1% metric, which indicates the peroxide concentration at which 1% of the enzyme molecules will be oxidatively inactivated per turnover (Nelson et al., 2013), XcPrxQ has a value of 1.4 mM, and so is roughly 20-times more robust than human Prx I and 7 times less robust than S. typhimurium AhpC (Fig. 2F, Table S2).
Figure 2.

In solution kinetics of XcPrxQ. A. Bisubstrate kinetics of XcPrxQ (0.2 μM) with hydrogen peroxide and EcTrxA at 5 μM (black), 10 μM (red), 20 μM (green) and 40 μM (blue). The curves are the results of the global fitting of all four data sets. B. Same as A, but for cumene peroxide and EcTrxA at 5 μM (black), 10 μM (red), 20 μM (green) and 50 μM (blue). C–D. Time courses showing XcPrxQ hyperoxidative activity loss during reactions with varying concentrations (as indicated) of hydrogen peroxide and cumene hydroperoxide, respectively. E. The fraction of protein inactivated per turnover (Wood et al., 2003) (finact) is plotted as a function of peroxide concentration for XcPrxQ hyperoxidation by hydrogen peroxide (closed circles) and cumene peroxide (open circles). F. Sensitivity of XcPrxQ to hyperoxidation by hydrogen peroxide (closed circles) is compared to literature data (Nelson et al., 2013) for human PrxI (open squares) and Salmonella typhimurium AhpC (open circles). See also Table S2 and Table S3.
High Precision Views of the FF and LU Active Sites
By pretreating the recombinant enzyme with dithiothreitol (DTT) we were able to grow FF crystals of the authentic reduced wild type form (Fig. 3A). These crystals diffracted to ~1.0 Å resolution, the best resolution so far for any Prx (Fig. S1). We were also able to replicate the crystals of the LU disulfide form (Fig. 3A) and extend their resolution to ~1.3 Å. For these structures, the high-quality electron density (Fig. 3B–C) clearly defines the active site geometry and allows us to precisely define, in the context of this model system, the active site interactions present in the substrate-ready FF active site (Fig. 1A–B) as well as those present in the disulfide form. In the unreacted protein, CP (Cys48) interacts closely with the Arg123 side chain, the Lys42 backbone NH, and two water molecules that roughly mimic the oxygens of a peroxide substrate (Fig. 1A & 3B). The structure of C48S (i.e. CP→Ser) looks nearly the same but has a bound phosphate that displaces the waters to similarly mimic substrate binding (see Fig. 5C). Like other Prx crystal structures (Hall et al., 2010), the wild type structure has the Thr45 side chain positioned to donate a hydrogen bond to the Lys42 carbonyl oxygen and not to the Cys48-Sγ (O···O distance of 2.9 Å, Thr-CB-Oγ···O-Lys42 angle = 114°) (Fig. 1A & 3B). This consistent high precision positioning of Thr45 matches that seen in previous Prx structures (Hall et al., 2010), but contrasts with computational studies that have modeled the conserved Thr as donating a hydrogen bond to the Cys thiolate and/or substrate oxygen (Zeida et al., 2014)(Portillo-Ledesma et al., 2014) (Fig. 1B–D). We further observe that rather than bonding directly to the thiolate or ligand, the distal Arg NH is oriented at an intermediary position where it could stabilize the transition of the peroxide oxygen to the Cys Sγ (Fig. 1B–C, Fig. 3B).
Figure 5.

Unusual Cys-sulfenate geometry. A. Packing interactions of the Cys-sulfenate are shown for structure FF3, highlighting interactions with the Cys-Sγ (gray dashes and distances in Å), with the sulfenate oxygen (black dashes and distances), and a possibly unfavorable interaction between Thr45-OH and the CP-SO− (red dash and distance). 2FO-FC electron density evidence for the sulfenate position is also shown (blue contoured at 1.0 ρrms). B. Interaction of the CP-thiolate with Pro41 (upper image) compared with that of the CP-sulfenate (at 0.5 occupancy and labeled with its unusual bond angle and distance reported; lower image). A brown arrow shows the shift of Pro41-Cγ accommodating the sulfenate formation by relieving a steric clash (red double-headed arrow) to increase the Pro41-Cγ to sulfenate oxygen distance to 3.6 Å. C. Structure of C48S XcPrxQ including bound water and phosphate (pink model) is compared with the XcPrxQ thiolate (FF0) and XcPrxQ sulfenate (FF3) forms (similar models both with white carbons; FF0 waters are gray spheres) and peroxide bound ApTpx (PDB code 3a2v, green carbons). Shift of the Pro is noted with a brown arrow. Notable observations are the C48S water and phosphate being near the FF3 Cys-sulfenate oxygen and the ApTpx peroxide, respectively. D. Gas phase quantum mechanical calculations (Zhao and Truhlar, 2008) of methyl SO−, SH2O+, and SH2O− species showing their energies as a function of their C-S-O bond angle (upper panel) as well as the optimized geometries and energies for the structures constrained to have a C-S-O angle of 155º. 3D figures were generated using CYLview (Legault, 2009). See Figures S4 and S5 for supporting details.
Structures along the Reaction Path
Since the crystalline wild type protein, unlike the CP→Ser mutant, is theoretically capable of catalysis if permitted by the crystal environment, we soaked the crystals with hydrogen peroxide, cumene hydroperoxide, and t-butyl hydroperoxide and found no loss in diffraction quality and conversion of CP to the CP-SO2− form (Fig. 4A,D and Fig. S2). After conducting initial experiments at pH 7.0, we performed additional substrate soaks varying peroxide concentrations and soak time, and also adjusted the pH to 4.5 speculating that a higher portion of protonated CP (CP-SH) could slow the reaction and allow us to better capture intermediates along the reaction pathway. This was successful and from a large set of structures solved, we selected a series of nine ~1 Å resolution structures – named FF0 through FF8 – that provide representative details of the transition of this Prx from CP-S− through CP-SO− to CP-SO2− (Fig. 4; Tables 1 and S1); a tenth structure, FF9, provides a fully-occupied CP-SO2− reference structure at pH=7. The FF0, FF3, FF5 and FF8 structures (Table 1) provide the best views of the CP-S− (occupancy ~1), CP-SO− (occupancy ~0.5), ‘inverted’ CP-SO− (occupancy ~0.1), and CP-SO2− (occupancy ~1) forms. The atomic resolution of these structures, with coordinate uncertainties of <0.05 Å, allow for a powerful dissection of the details of catalysis, including the reliable recognition of low occupancy intermediates and alternative conformations of active site residues.
Figure 4.
Atomic resolution snapshots of XcPrxQ catalysis. A–D. Structures FF0, FF3, FF5 and FF8, respectively, are shown with their 2FO-FC electron density (blue contoured at 1.0 ρrms) and difference electron density between the structure of interest and FF0 (green and red contoured at ±3.0 ρrms). In panels B–D, key shifts in active site residues are indicated by brown arrows with the conserved Pro flipping between two positions (noted as P1 and P2) and the Arg transitioning among three positions (R1, R2, R3). E. CP is shown with occupancies of its oxygen adducts indicated by color (from light to dark red). 2FO-FC density is shown (blue contoured at 1.0 ρrms and for the sulfenate oxygen in FF1 olive contoured at 0.3 ρrms). Density near the top of the image in structures FF4–FF7 is from a partially-occupied Arg conformation that occurs as the protein converts from the sulfenate to sulfinate state. F. A single image showing the 2FO-FC electron density peaks for CP oxygens from all structures as single planes (solid colors at 1.0 ρrms, red outline 0.3 ρrms). The overlay shows the progression of the oxidation of CP: from 10% SO− (red outline; FF1), 45% SO− (orange; FF2), 50% SO− (yellow; FF3), 10% SO2− (light green; FF4), 20% SO2− (cyan; FF5), 20% SO2− (blue; FF6), 35% SO2− (dark blue; FF7), 100% SO2−, (purple; FF8). All structural images were prepared using Pymol. See also Figure S3 and Figure S4.
Peroxidation (FF1 through FF3)
A known value of ultra-high resolution crystallography is its ability to provide definitive evidence for unexpected structures. Here, we were surprised that the clearly defined putative SO− intermediate is stabilized in the crystal with a Cβ-Sγ-Oδ bond angle of 153° (compared to the expected ~110 degrees (Engh and Huber, 1991)) and a short 1.38 Å Sγ-Oδ bond length (Fig. 5A,B). To our knowledge, such a bond angle has not been previously observed for a Cys-sulfenate. This is a reliable crystallographic result as we observed it in seven independent crystal structures: five H2O2 soaks at pH 4.5, one H2O2 soak at pH 7.0, and one t-butyl hydroperoxide soak at pH 7.0. The only standard hydrogen bond visible to the SO− oxygen is from Arg123, but the moiety as a whole is fully surrounded by a tightly packed and well-ordered active site with low B-factors (Figs. 5A and 3A) that changes little between oxidation states. The presence of the sulfenate Oδ causes a conformation change of Pro41, which flexes from an exo to an endo rotamer to avoid a steric clash (Fig. 5B). Importantly, the change in Pro41 is also at half occupancy matching that of the SO− oxygen. Interestingly, with this change the Pro41-CδH atom is positioned to make a C-H hydrogen bond (Derewenda et al., 1995) to the SO− oxygen (Fig. 5A). In a fortuitous related result, the structure of the C48S mutant contains a fully bound water in roughly the same position as the SO− oxygen, and it similarly induces the Pro41 conformation change (Fig. 5C). This C48S structure provides evidence that despite the lack of multiple strong conventional hydrogen bonds, this is a thermodynamically favorable position for oxygen binding.
To better understand how this intermediate could adopt such an unexpected bond angle and length, we performed gas phase quantum mechanical (QM) computations of a variety of model methyl SOH and SO− species (Figs. 5D, S4 and S5). These species incurred severe energetic penalties to adopt the observed geometry (~40–50 kcal/mol). Interestingly, a doubly protonated methyl SH2O− sulfenate species only exhibited ~9 kcal/mol of energetic penalty for adopting the 153° angle (Fig. 5D). As we mentioned above, an Arg123-NH and a backbone amide (Lys42) provide universally conserved hydrogen bond interactions to the Sγ atom (Figs. 1A and 5A), and the geometry of these hydrogen bonding interactions are such that they may cause electronic effects that are similar to those caused by the double protonation. So while further studies are certainly needed to fully understand the nature of the structure seen, we hypothesize that the electrostatic (including hydrogen bonding) environment of the active site may help make this structure energetically accessible.
Hyperoxidation (FF4 through FF8)
Fortuitously, our model system allowed us to not only capture each chemical state of the catalytic cycle, but also aspects of the transition from CP-SO− to the hyperoxidized CP-SO2− state (Fig. 4). In particular, structures FF4 through FF7 give evidence of a predicted (Hall et al., 2010) intermediate along this reaction pathway in which the SO− rotates inward toward Arg123 to adopt what we call an ‘inverted’ position, and vacates the substrate binding site to permit reaction with a second peroxide. To accommodate the inverted sulfenate oxygen the side chain of Arg123 flips out of the active site and away from CP (Fig 4C). Upon reaction with the second peroxide, Arg123 repositions to a third conformation to coordinate with the oxygens of the newly formed CP-SO2− (Fig. 4D). Interestingly, we note for this bacterial Prx that both the inverted CP-SO− and CP-SO2− reaction states along the hyperoxidation pathway perturb the Arg from its normal catalytic position.
Since XcPrxQ in solution is rather robust against hyperoxidation (Fig. 2F, Table S3), it was surprising that the protein in the crystal was so readily hyperoxidized and that the CP-SO− only accumulated to a maximal level of ~50%. In fact, for crystalline XcPrxQ the protein becomes fully hyperoxidized (with no disulfide formation) in a single turnover whereas only ~7 % would be expected to become hyperoxidized in solution at the same peroxide concentration (Fig. 2F). This can be easily understood in that crystal contacts block the protein from ever unfolding, effectively dropping the rate of disulfide bond formation to zero in the crystal compared with the solution rate of ~27 s−1 (Table S2). In fact, crystal contact interactions occur at all four regions involved in local unfolding (Fig. 6A). While we cannot dissect how much each crystal contact contributes, we note that at one contact, Arg103 of a symmetry mate directly blocks disulfide formation by preventing rearrangement of the CR-containing α3 helix (Fig. 6B).
Figure 6.

Non-covalent stabilization of the FF conformation can promote hyperoxidation. A. Protein surface area buried by crystal contacts (gray) has substantial overlap with magnitudes of conformation change (red) on a per residue basis along the chain. The CP (Cys48) and CR (Cys84) positions are denoted (*). Residues 79–81, not well defined in the LU structure, were assigned a shift of 10 Å based on their neighbors. B. One crystal contact region in the FF XcPrxQ crystals (white for main molecule and gray for symmetry mate) overlaid with LU structure (black) shows FF→LU movement (brown arrows) of Phe83 is prevented by a steric clash with Arg103 of the symmetry mate (red) because the two side chains would be 1.3 Å apart. C. A general mechanism for Prx catalysis and hyperoxidation is shown, as has been previously proposed (Sevilla et al., 2015)(Perkins et al., 2015)(Perkins et al., 2014), that highlights the key physiologically-relevant redox states that have been captured at atomic resolution for XcPrxQ. Also emphasized is that inhibiting facile unfolding enhances inactivation. This has been observed to occur for sensitive Prx1-subfamily members by stabilization by the C-terminal tail (Wood et al., 2003). In the case of XcPrxQ, the FF crystal form can be conceptually considered as a large non-covalent FF-conformation-stabilizing inhibitor, trapping the enzyme as FF and promoting inactivation.
Modulating the switch between local unfolding and hyperoxidation pathways
Susceptibility of Prxs to hyperoxidation and inactivation is of broad biological signicance, as to survive pathogens must avoid having their Prxs inactivated by host-secreted reactive oxygen species, and inactivation is required as part of eukaryotic signaling pathways (Perkins et al., 2014). The structures reported here provide insight into the structural features involved in determining whether the protein in the CP-SO− state will undergo local unfolding or become hyperoxidized. For bacterial XcPrxQ, several lines of evidence indicate that sulfenate formation is destabilizing to the active site and promotes local unfolding. Initial formation of the sulfenate in XcPrxQ resulted in a high energy CP-SO− structure. As to why this sulfenate deviates so significantly from its ground state geometry, the main thing we notice is that the FF active site changes minimally between the thiolate (S−) and sulfenate (SO−) forms (Fig. 5C), and that within an unperturbed FF active site, the CP-SO− sulfenate oxygen appears to be sterically and electrostatically hindered by the Thr45 side chain from adopting a relaxed position (Fig. 5A). We expect that in solution the unfavorable interactions would be releaved by local unfolding of the active site and facilitate formation of the CP-CR disulfide, and we only observe this high energy conformation in the crystalline enzyme because of the stabilization of the FF active site conferred by the crystal contacts. Stated another way, for sulfenate formation there are two possibilities: the CP-SO− adopts a relaxed geometry while perturbing the FF active site (i.e. promoting local unfolding) or the FF active site remains intact and the CP-SO− adopts a high energy conformation compatible with its environment.
Interestingly, it has been observed that adopting a ground state sulfenate geometry perturbs the active site for Prxs from two other subfamilies. For human Prx6 (PDB entry 1prx)(Cao et al., 2011) the conserved Arg is swung away to make room for the modification, and for Mycobacterium tuberculosis AhpE (PDB entry 1xwv), a 1-Cys Prx, changes occur for both Arg and Thr positions (Li et al., 2005). Lastly, the tradeoff between sulfenate conformation and active site stability may explain the origin of the unusual hypervalent CP-sulfurane-His intermediate formed in peroxide soaks of crystals of the A. pernix thiol peroxidase (Nakamura et al., 2008); perhaps the intermediate is a high energy structure that forms in the crystal only because crystal contacts hinder the local unfolding that would normally be promoted by CP-SO− formation.
A second structural determinant revealed in the XcPrxQ structures is how the transient inverted CP-SO− affects the active site of a robust bacterial Prx. The rotation of the sulfenate oxygen to point back into the tightly packed active site causes the Arg to flip outward. Similar to the unfavorable geometry observed following initial peroxidation, these rearrangements would appear to promote local unfolding for the protein, and could also reduce the rate of hyperoxidation by removing the Arg’s contributions to substrate binding and activation. Interestingly, we do not see the Arg to shift in response to an inverted oxygen position in sulfinate structures from sensitive Prx enzymes, such as human PrxII (PDB entry 1qmv)(Kitano et al., 2005), implying that sensitive Prxs could in part favor hyperoxidation over local unfolding by having evolved to better accommodate the inverted oxygen position in an FF active site.
Overall, the hyperoxidation pathway observed in the XcPrxQ structures reveal there are at least three ways the sensitivity of a Prx isoform can be tuned. First, hyperoxidation can be hindered if CP-sulfenate formation directly destabilizes the FF active site through unfavorable steric and electrostatic interactions, favoring local unfolding and promoting disulfide formation. Second, hyperoxidation can independently be further disfavored if the FF active site is destabilized when the sulfenate oxygen rotates to the inverted position and makes room for the second peroxide substrate to bind. Third, an enhancement of hyperoxidation can be accomplished through any set of interactions that disfavor local unfolding. In naturally sensitive Prx1 subfamily enzymes, a C-terminal extension buttresses and stabilizes the FF active site to inhibit unfolding and disulfide formation (Wood et al., 2003)(Perkins et al., 2014), and in the XcPrxQ crystals the functional equivalent of these interactions are the crystal contacts. An intriguing possibility is that this functionality could be exploited to design conformation-trapping inhibitors to selectively target pathogen Prxs (Perkins et al., 2014) (Perkins et al., 2013). The advantage conferred by this strategy is that differences in FF↔LU conformational changes between human and pathogen isoforms could be leveraged to design inhibitors that bind regions other than the conserved active site, avoiding the potential for toxicity from disrupting human Prx function.
CONCLUSION
In summary, the ultra-high resolution structures reported here reveal in the context of bacterial XcPrxQ an unprecedented level of detail about active site interactions covering the full cycle of Prx catalysis (Fig. 6C). These structures directly add to our knowledge of the Prx mechanism, and will serve as ideal starting models for future computational studies of both the initial peroxidation reaction and hyperoxidative inactivation. An unusual Cys-sulfenate geometry is observed (<Cβ-Sγ-Oδ = 153º) that quantum mechanical computations reveal incurs a severe energetic penalty that may be made more energetically accessible in the presence of strong hydrogen-bonds to the Sγ. From these results, we hypothesize that formation of the high energy sulfenate potently induces the active site to locally unfold. Additionally, although several computational studies by others have modeled the conserved Thr as donating a hydrogen bond to the Cys thiolate and/or substrate oxygen (Zeida et al., 2014)(Portillo-Ledesma et al., 2014), consistent with previous structural studies of other Prxs (Hall et al., 2010) we find no evidence for such an interaction in the atomic resolution structures of XcPrxQ. Perhaps some of these discrepencies may be due to the exclusion of the universally conserved Pro and surrounding residues in earlier computational studies. Indeed, as with all model systems, the beneficial ease and simplicity of analysis conferred by aspects of XcPrxQ functionality come at the cost of limitations that some Prxs, a family that includes members separated by billions of years of evolution, may behave differently. Our structures here most directly represent the behavior of a robust bacterial Prx and further work will be required to explore how similar our observations are across the very diverse Prx family. However, we note that the XcPrxQ model system has the key Pro, Thr, Cys, and Arg residues conserved across all Prxs, and so we expect should be representative of the peroxidatic step, even though isoforms vary in the manner they locally unfold and in their susceptibility to hyperoxidation.
EXPERIMENTAL PROCEDURES
Materials & Methods
Cloning, Expression, and Purification
The gene for XcPrxQ, codon-optimized for expression in E. coli and synthesized by GenScript (Piscataway, NJ), was cloned between the NcoI and HindIII sites of pTHCm(Nelson et al., 2008) to express a non-His-tagged protein. Mutations were created using the QuikChange II method (Agilent). Expression was carried out in strain B834, using ZYM-5052 auto-induction medium at 37 °C (Studier, 2005). Purifications were done at 4 °C. Cells were disrupted using an Avestin C5 homogenizer, nucleic acids removed using streptomycin sulfate, and after overnight dialysis against 10 mM Tris-Cl, pH 8.0, 0.5 mM EDTA and centrifugation, the supernatant was loaded onto a 75 mL Q-Sepharose HP (GE Healthcare) column. XcPrxQ was eluted using a 0→1 M NaCl gradient, with XcPrxQ-containing fractions precipitated at 75 % saturating ammonium sulfate. The protein pellet was dissolved in a minimal volume of 25 mM potassium phosphate, pH 7.0, 1 mM EDTA and 0.1 M NaCl, and loaded onto a 250 mL Superose 12PG (GE Healthcare) column equilibrated with the same buffer. For assays, pure protein was buffer-exchanged into 20 mM Tris-Cl, pH 8.0, 1 mM EDTA, and concentrated to 10 mg ml−1 by ultrafiltration, and frozen at −80 °C in aliquots. E. coli thioredoxin 1 (TrxA) and thioredoxin reductase (TrxR) were expressed and purified as previously described (Reeves et al., 2011).
Crystallography
Crystallization
After exchanging the wild type protein into 20 mM Tris pH 7.0, 20 mM sodium chloride, 1 mM EDTA, protein at 10 mg/ml was initially crystallized using conditions from Liao et al. (Liao et al., 2009). Crystal seeding greatly increased crystal size and growth rate. For wild type XcPrxQ in the locally unfolded disulfide form (LUss) optimal growth at 300 K occurred within three days in 4:1 protein:reservoir drops with a reservoir of 1.0 M ammonium sulfate, 0.2 M sodium chloride, 0.1 M sodium cacodylate, pH 6.8. From stacks of plate-like crystals, single plates were extracted into a 10 μL drop of AML containing a cryoprotectant of 4.5 M sodium formate, equilibrated for three minutes, then scooped and plunged into liquid nitrogen. Attempts at reducing the disulfide by chemical reductants were unsuccessful.
For initially crystallizing wild type XcPrxQ in the fully folded form (FF), the protein was pre-treated for 10 minutes with 10 mM DTT, and 10 mM fresh DTT was added to the condition previously reported to crystallize the C48S/C84S double mutant (Liao et al., 2009). After optimization, crystals were grown at 300 K in 6:2 μl protein:reservoir hanging drops with 8 mg/ml protein stock and a reservoir of 30% PEG 4000, 0.1 M sodium acetate pH 5.5, 10 mM DTT. Individual crystals were transferred to fresh 10 μL drops containing an AML of 18% PEG 4000, 0.1 M Tris, pH 7.0, and 4.5 M sodium formate, equilibrated for three minutes, scooped and plunged in liquid nitrogen.
For the wild type FF crystals, time courses at pH 7.0 were conducted with 10 mM t-butyl hydroperoxide or cumene hydroperoxide, and at pH 4.5 or 7.0 with 10 mM hydrogen peroxide, in a 10 μL drop. Substrate soaks were performed at 300 K by adding 1.0 μL of an 100 mM peroxide stock to a crystal-containing drop of 9 μL of AML with either 0.1 M sodium acetate (pH 4.5) or 0.1 M Tris (pH 7.0), and after between 5 s and 10 mins scooping and plunging the crystal into liquid nitrogen. A 10 mM substrate concentration was chosen as an amount that would not readily oxidize other residues non-specifically (Drozdź et al., 1988) but was enough to readily oxidize CP. That lower concentrations such a 1 mM did not consistently succeed can be explained by recognizing that for average crystals of ~1 × 0.5 × 0.2 mm3 (containing ca. 1.4 × 1015 XcPrxQ molecules), 1 mM peroxide in a 10 μL drop only provides roughly a 4:1 ratio of peroxide to protein. Due to the varying size and shapes of crystals, soak duration was only roughly correlated with the redox state observed in the structure. For this reason, we collected data on crystals with many different soak times to obtain structures for reaction intermediates.
The C48S and C84S single mutants crystallized in similar conditions to the wild type FF, in a protein buffer of 25 mM potassium phosphate, pH 7.0, 1 mM EDTA and 0.1 M NaCl. Optimal conditions for C48S were 3:1 μL protein:reservoir drops using a 6 mg/ml protein stock and a 40% PEG 4000, 0.1 M sodium acetate pH 5.5 reservoir. C84S crystallized in 4:1 μL protein:reservoir drops with 9.2 mg/ml protein stock and a reservoir of 35% PEG 4000, 0.1 M sodium acetate pH 5.5, 1 mM DTT. The C84S structure demonstrated no major differences other than a shift in the Ser position relative to the wild type Cys (Fig. S3), but we have included it here as it is the highest resolution structure for a CR mutant form and may be useful for future studies. As for wild type, these crystals were generally equilibrated in a 10 μL drop of AML at pH 7.0 prior to freezing. The one exception was a C48S crystal harvested directly from its drop (at pH 5.5) that yielded the phosphate-bound structure. Crystals of wild type and C84S scooped directly from their drops did not yield phosphate-bound structures.
Data Collection
Data were collected at the Advanced Light Source at Lawrence Berkeley National Labs on beamlines 5.0.1, 5.02, and 5.03 at cryo-temperatures. Data were indexed and integrated with iMosflm 7.0.9 (Battye et al., 2011), and found to be in the two expected P21 crystal forms for LUss (wild type) and FF crystals (yielding wild type, C48S, and C84S structures) (Table 1, Table S1)(Liao et al., 2009). Though both crystal forms coincidently have P21 symmetry, they have different unit cells and crystal packing interactions.
Refinement
For the FF structures, the main initial changes from entry 3gkm were the addition of ca. 100 water molecules now visible with the improved resolution and an alternate chain path for residues 65–67. Additionally, mass spectrometry implied the N-terminal methionine had been lost and an acetyl group gained, and this modification was reasonably clear in the electron density and was modeled. Several solvent sites exhibiting strong electron density and close bond distances of ~2.1 Å were modeled as Na+ ions, present in the protein buffer, crystallization conditions, and cryoprotectant. Continuous density near Cys84 may be a disordered PEG molecule, but was left unmodeled. Strong density for a tetragonal ligand was seen in the C48S active site at pH 5.5. This was modeled as a phosphate since the protein buffer contained 25 mM phosphate and because anomalous maps showed strong peaks for cysteine sulfur atoms but no signal at the ligand peak. In late stages of refinement, riding hydrogens were added, reducing Rfree by ~1 %. Subsequently, individual anisotropic B-factors were introduced for all non-hydrogen atoms, reducing Rfree by a further 2–3 %.
For wild type structures treated with substrate, the occupancies of oxygen adducts were estimated from the relative strength of the electron density, with the expectation that B-factors would be slightly higher for the oxygen positions than the Sγ, the requirement that occupancies must add to 100%, the knowledge of the atom positions in the thiolate, sulfenate, and sulfinic acid forms based on clear high occupancy structures for each of those, and also using information from active site rearrangements that appear to be correlated with the redox changes at CP. The final occupancies chosen also minimized residual difference peaks. We could not explicitly distinguish between sulfenate and sulfenic acid forms which differ by only a hydrogen (for example between alternate conformations of sulfenate and low occupancy sulfinate). We tested if the extended sulfenate angle could be the result of radiation damage from data collection, but analysis of only the first 90 diffraction images still show the clearly-defined adduct.
Quantum mechanical computations
All quantum mechanical computations were performed in the gas phase using M06-2X(Zhao and Truhlar, 2008)/6-31G*(Miertuš et al., 1981) level of theory as implemented in Gaussian 09.(Frisch et al., 2009) Ten methyl sulfenate (SO−) and sulfenic acid (SOH) species of varying oxidation and protonation states were computed for a series of geometries with varying C-S-O angles from 95º to 155º in 5º increments (Figs. 5D, S4, & S5). For the methyl SOH species, the torsional angle around the S-O bond was rotated 360º in 10º increments for each C-S-O angle increment to capture the minimum energy pathway We benchmarked M06-2X/6-31G* results against energies from fifteen quantum mechanical methods including the high accuracy DLPNO-CCSD(T) (Fig. S5). The employed method yields consistent results at a lesser computational expense.
Measurement of Kinetic Properties
XcPrxQ activity was measured by following the decrease in fluorescence of E. coli thioredoxin, TrxA, as the reductant of XcPrxQ in reaction mixtures with H2O2 or cumene hydroperoxide, as described by Parsonage et al (2010) (Parsonage et al., 2010). Values for Vmax and Km for both peroxide and TrxA substrates were calculated directly from global fits of all of the data for each peroxide substrate by using the multiple-function nonlinear regression capability of SigmaPlot (SYSTAT software)(Parsonage et al., 2010). The kinetic data using were fit to a model of saturable interactions (defined KM) for each substrate, but the KM for interaction of EcTrxA with XcPrxQ is not well determined given the concentrations used (Table S2). Steady state kinetic parameters from these global fits are reported in Table S2.
Hyperoxidation of XcPrxQ (1 μM) was measured in the presence of 1 μM EcTrxA, 0.1 μM EcTrxR, 150 μM NADPH, and either CHP or H2O2 (0.1, 0.2, 0.5, 1, 2, and 5 mM) in 25 mM potassium phosphate, pH 7.0, 1 mM EDTA, 100 mM ammonium sulfate at 25 °C with a Varian Cary 50 UV-Vis spectrophotometer by monitoring absorbance at 340 nm. As the Prx protein becomes hyperoxidized over the course of the reaction (with a fraction inactivated during each turnover), the absorbance change over time increasingly deviates from linear kinetics. The kinetic trace was fit to an exponential decay model to describe inactivation sensitivity using the previously introduced Chyp1% metric, which indicates the peroxide concentration at which 1% of the enzyme molecules will be oxidatively inactivated per turnover(Nelson et al., 2013). Steady state kinetic parameters from these global fits are reported in Table S2. Inactivation of XcPrxQ over 15 min during turnover with peroxide concentrations in excess of 0.1 mM was detectable and yielded a Chyp1% value of 1.43 mM for H2O2 (Table S3).
Supplementary Material
Acknowledgments
This research was funded in part by National Institutes of Health grants GM050389 and GM119227 to LBP and PAK. PHYC is the Bert and Emelyn Christensen professor and acknowledges financial support from the Stone family of OSU. PHYC and OMO acknowledge computing infrastructure in part provided by the National Science Foundation Phase-2 CCI, Center for Sustainable Materials Chemistry (CHE-1102637). The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.
Abbreviations
- Prx
peroxiredoxin
- TrxA
thioredoxin 1
- Srx
sulfiredoxin
- PDB
protein databank
- CP
peroxidatic cysteine
- CR
resolving cysteine
- FF
fully folded
- LU
locally unfolded
- XcPrxQ
Xanthomonas campestris peroxiredoxin Q
- ML
mother liquor
- AML
artificial mother liquor
- ρrms
root-mean-square electron density
Footnotes
Author Contributions.
A.P. designed experiments, performed protein purification, crystallization, data analysis and interpretation, and wrote the text. D. P. performed cloning, protein purification, kinetic experiments, and reviewed the text. K. J. N. performed hyperoxidation experiments and reviewed the text. O. M. O. and P. H.-Y. C. performed all quantum mechanical computations and reviewed the text. L. B. P. and P. A. K. contributed to experimental design, data analysis, writing, and critical review of the text.
References
- Afonine PV, Grosse-Kunstleve RW, Echols N, Headd JJ, Moriarty NW, Mustyakimov M, Terwilliger TC, Urzhumtsev A, Zwart PH, Adams PD. Towards automated crystallographic structure refinement with phenix refine. Acta Crystallographica Section D Biological Crystallography. 2012;68:352–367. doi: 10.1107/S0907444912001308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Battye TGG, Kontogiannis L, Johnson O, Powell HR, Leslie AGW. iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallographica Section D Biological Crystallography. 2011;67:271–281. doi: 10.1107/S0907444910048675. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buchko GW, Perkins A, Parsonage D, Poole LB, Karplus PA. Backbone chemical shift assignments for Xanthomonas campestris peroxiredoxin Q in the reduced and oxidized states: a dramatic change in backbone dynamics. Biomol NMR Assign. 2015:1–5. doi: 10.1007/s12104-015-9637-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cao Z, Tavender TJ, Roszak AW, Cogdell RJ, Bulleid NJ. Crystal structure of reduced and of oxidized peroxiredoxin IV enzyme reveals a stable oxidized decamer and a non-disulfide-bonded intermediate in the catalytic cycle. J Biol Chem. 2011;286:42257–42266. doi: 10.1074/jbc.M111.298810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davis IW, Murray LW, Richardson JS, Richardson DC. MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Research. 2004;32:W615–W619. doi: 10.1093/nar/gkh398. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Derewenda ZS, Lee L, Derewenda U. The Occurence of C–H · · · O Hydrogen Bonds in Proteins. Journal of Molecular Biology. 1995;252:248–262. doi: 10.1006/jmbi.1995.0492. [DOI] [PubMed] [Google Scholar]
- Driggers CM, Cooley RB, Sankaran B, Hirschberger LL, Stipanuk MH, Karplus PA. Cysteine Dioxygenase Structures from pH 4 to 9: Consistent Cys-Persulfenate Formation at Intermediate pH and a Cys-Bound Enzyme at Higher pH. Journal of Molecular Biology. 2013;425:3121–3136. doi: 10.1016/j.jmb.2013.05.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Drozdź R, Naskalski JW, Sznajd J. Oxidation of amino acids and peptides in reaction with myeloperoxidase, chloride and hydrogen peroxide. Biochim Biophys Acta. 1988;957:47–52. doi: 10.1016/0167-4838(88)90155-0. [DOI] [PubMed] [Google Scholar]
- Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallographica Section D Biological Crystallography. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
- Engh RA, Huber R. Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallographica Section A Foundations of Crystallography. 1991;47:392–400. [Google Scholar]
- Evans PR, Murshudov GN. How good are my data and what is the resolution? Acta Crystallographica Section D Biological Crystallography. 2013;69:1204–1214. doi: 10.1107/S0907444913000061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frisch Mj, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, et al. Gaussian 09, revision A. 02. Vol. 19. Gaussian, Inc; Wallingford, CT: 2009. pp. 227–238. [Google Scholar]
- Hall A, Karplus PA, Poole LB. Typical 2-Cys peroxiredoxins – structures, mechanisms and functions. FEBS Journal. 2009;276:2469–2477. doi: 10.1111/j.1742-4658.2009.06985.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hall A, Parsonage D, Poole LB, Karplus PA. Structural Evidence that Peroxiredoxin Catalytic Power Is Based on Transition-State Stabilization. Journal of Molecular Biology. 2010;402:194–209. doi: 10.1016/j.jmb.2010.07.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Horta BB, Oliveira MAD, Discola KF, Cussiol JRR, Netto LES. Structural and Biochemical Characterization of Peroxiredoxin Qβ from Xylella Fastidiosa CATALYTIC MECHANISM AND HIGH REACTIVITY. J Biol Chem. 2010;285:16051–16065. doi: 10.1074/jbc.M109.094839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Karplus PA, Diederichs K. Linking Crystallographic Model and Data Quality. Science. 2012;336:1030–1033. doi: 10.1126/science.1218231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kil IS, Lee SK, Ryu KW, Woo HA, Hu MC, Bae SH, Rhee SG. Feedback Control of Adrenal Steroidogenesis via H2O2-Dependent, Reversible Inactivation of Peroxiredoxin III in Mitochondria. Molecular Cell. 2012;46:584–594. doi: 10.1016/j.molcel.2012.05.030. [DOI] [PubMed] [Google Scholar]
- Kitano K, Kita A, Hakoshima T, Niimura Y, Miki K. Crystal structure of decameric peroxiredoxin (AhpC) from Amphibacillus xylanus. Proteins. 2005;59:644–647. doi: 10.1002/prot.20412. [DOI] [PubMed] [Google Scholar]
- Legault CY. CYLview, version 1.0 b. Université de Sherbrooke; Sherbrooke, Quebec, Canada: 2009. [Google Scholar]
- Li S, Peterson NA, Kim MY, Kim CY, Hung LW, Yu M, Lekin T, Segelke BW, Lott JS, Baker EN. Crystal Structure of AhpE from Mycobacterium tuberculosis, a 1-Cys peroxiredoxin. Journal of Molecular Biology. 2005;346:1035–1046. doi: 10.1016/j.jmb.2004.12.046. [DOI] [PubMed] [Google Scholar]
- Liao SJ, Yang CY, Chin KH, Wang AHJ, Chou SH. Insights into the Alkyl Peroxide Reduction Pathway of Xanthomonas campestris Bacterioferritin Comigratory Protein from the Trapped Intermediate–Ligand Complex Structures. Journal of Molecular Biology. 2009;390:951–966. doi: 10.1016/j.jmb.2009.05.030. [DOI] [PubMed] [Google Scholar]
- Lowther WT, Haynes AC. Reduction of Cysteine Sulfinic Acid in Eukaryotic, Typical 2-Cys Peroxiredoxins by Sulfiredoxin. Antioxidants & Redox Signaling. 2010;15:99–109. doi: 10.1089/ars.2010.3564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miertuš S, Scrocco E, Tomasi J. Electrostatic interaction of a solute with a continuum. A direct utilizaion of AB initio molecular potentials for the prevision of solvent effects. Chemical Physics. 1981;55:117–129. [Google Scholar]
- Nagy P, Karton A, Betz A, Peskin AV, Pace P, O’Reilly RJ, Hampton MB, Radom L, Winterbourn CC. Model for the Exceptional Reactivity of Peroxiredoxins 2 and 3 with Hydrogen Peroxide A KINETIC AND COMPUTATIONAL STUDY. J Biol Chem. 2011;286:18048–18055. doi: 10.1074/jbc.M111.232355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakamura T, Yamamoto T, Abe M, Matsumura H, Hagihara Y, Goto T, Yamaguchi T, Inoue T. Oxidation of archaeal peroxiredoxin involves a hypervalent sulfur intermediate. PNAS. 2008;105:6238–6242. doi: 10.1073/pnas.0709822105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nelson KJ, Parsonage D, Hall A, Karplus PA, Poole LB. Cysteine pKa Values for the Bacterial Peroxiredoxin AhpC†‡. Biochemistry. 2008;47:12860–12868. doi: 10.1021/bi801718d. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nelson KJ, Knutson ST, Soito L, Klomsiri C, Poole LB, Fetrow JS. Analysis of the peroxiredoxin family: Using active-site structure and sequence information for global classification and residue analysis. Proteins: Structure, Function, and Bioinformatics. 2010;79:947–964. doi: 10.1002/prot.22936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nelson KJ, Parsonage D, Karplus PA, Poole LB. Evaluating peroxiredoxin sensitivity toward inactivation by peroxide substrates. Meth Enzymol. 2013;527:21–40. doi: 10.1016/B978-0-12-405882-8.00002-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parsonage D, Desrosiers DC, Hazlett KRO, Sun Y, Nelson KJ, Cox DL, Radolf JD, Poole LB. Broad specificity AhpC-like peroxiredoxin and its thioredoxin reductant in the sparse antioxidant defense system of Treponema pallidum. PNAS. 2010;107:6240–6245. doi: 10.1073/pnas.0910057107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perkins A, Gretes MC, Nelson KJ, Poole LB, Karplus PA. Mapping the Active Site Helix-to-Strand Conversion of CxxxxC Peroxiredoxin Q Enzymes. Biochemistry. 2012;51:7638–7650. doi: 10.1021/bi301017s. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perkins A, Nelson KJ, Williams JR, Parsonage D, Poole LB, Karplus PA. The Sensitive Balance between the Fully Folded and Locally Unfolded Conformations of a Model Peroxiredoxin. Biochemistry. 2013;52:8708–8721. doi: 10.1021/bi4011573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perkins A, Poole LB, Karplus PA. Tuning of Peroxiredoxin Catalysis for Various Physiological Roles. Biochemistry. 2014;53:7693–7705. doi: 10.1021/bi5013222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perkins A, Nelson KJ, Parsonage D, Poole LB, Karplus PA. Peroxiredoxins: guardians against oxidative stress and modulators of peroxide signaling. Trends Biochem Sci. 2015;40:435–445. doi: 10.1016/j.tibs.2015.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Portillo-Ledesma S, Sardi F, Manta B, Tourn MV, Clippe A, Knoops B, Alvarez B, Coitino EL, Ferrer-Sueta G. Deconstructing the catalytic efficiency of peroxiredoxin-5 peroxidatic cysteine. Biochemistry. 2014 doi: 10.1021/bi500389m. [DOI] [PubMed] [Google Scholar]
- Reeves SA, Parsonage D, Nelson KJ, Poole LB. Kinetic and Thermodynamic Features Reveal That Escherichia coli BCP Is an Unusually Versatile Peroxiredoxin. Biochemistry. 2011;50:8970–8981. doi: 10.1021/bi200935d. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rhee SG, Woo HA, Kil IS, Bae SH. Peroxiredoxin Functions as a Peroxidase and a Regulator and Sensor of Local Peroxides. J Biol Chem. 2012;287:4403–4410. doi: 10.1074/jbc.R111.283432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rouhier N, Gelhaye E, Gualberto JM, Jordy MN, Fay ED, Hirasawa M, Duplessis S, Lemaire SD, Frey P, Martin F, et al. Poplar Peroxiredoxin Q. A Thioredoxin-Linked Chloroplast Antioxidant Functional in Pathogen Defense. Plant Physiol. 2004;134:1027–1038. doi: 10.1104/pp.103.035865. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sevilla F, Camejo D, Ortiz-Espín A, Calderón A, Lázaro JJ, Jiménez A. The thioredoxin/peroxiredoxin/sulfiredoxin system: current overview on its redox function in plants and regulation by reactive oxygen and nitrogen species. J Exp Bot. 2015:erv146. doi: 10.1093/jxb/erv146. [DOI] [PubMed] [Google Scholar]
- Studier FW. Protein production by auto-induction in high-density shaking cultures. Protein Expression and Purification. 2005;41:207–234. doi: 10.1016/j.pep.2005.01.016. [DOI] [PubMed] [Google Scholar]
- Wood ZA, Poole LB, Karplus PA. Peroxiredoxin Evolution and the Regulation of Hydrogen Peroxide Signaling. Science. 2003;300:650–653. doi: 10.1126/science.1080405. [DOI] [PubMed] [Google Scholar]
- Zeida A, Reyes AM, Lebrero MCG, Radi R, Trujillo M, Estrin DA. The extraordinary catalytic ability of peroxiredoxins: a combined experimental and QM/MM study on the fast thiol oxidation step. Chem Commun. 2014;50:10070–10073. doi: 10.1039/c4cc02899f. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhao Y, Truhlar DG. The M06 suite of density functionals for main group thermochemistry, thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new functionals and systematic testing of four M06-class functionals and 12 other functionals. Theoretical Chemistry Accounts. 2008;120:215–241. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

